NCT00021996View on ClinicalTrials.gov

Valdecoxib in Treating Chronic Pain in Cancer Patients

NACompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Study Completion Date

February 29, 2004

Conditions
PainUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

valdecoxib

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT00021996 - Valdecoxib in Treating Chronic Pain in Cancer Patients | Biotech Hunter | Biotech Hunter